Surfing the web, I uncovered these news items worth sharing

• A recent paper in NEJM discusses the call from global leaders on the importance of sharing cancer data to save lives. The Global Alliance for Genomics and Health argue that sharing cancer data will allow researchers to develop better treatments.
• Researchers at Northwestern University have found that a new cancer drug for the treatment of leukemia and lymphoma may also treat food allergies. This FDA-approved drug is ibrutinib and more on this discovery in the Journal of Allergy and Clinical Immunology.
• In a recent article published by Reuters, it was reported that UK-funded cancer research scientists will conduct a study to see if the Zika virus can destroy brain tumor cells in hopes of developing new treatments for one of the most difficult cancers to treat.
• Scientists at Washington University in St. Louis in collaboration with colleagues at California Institute of Technology have developed a technology to scan a tumor sample and produce images detailed and accurate enough to be used to check whether a tumor has been completely removed. More in Science Advances.

The latest in Cancer Research News

• Researchers at the UT Southwestern Medical Center have developed a nanoparticle vaccine immunotherapy that targets several different cancer types. The nanoparticle vaccine delivers minuscule particulates that stimulate the immune system to mount an immune response.  Read more about the vaccine in Nature Nanotechnology.
• A study led by researchers at Keele University shows that men and women suffering from heart failure have a higher risk of death than people with most common types of cancer. The data for this study was collected between 2000-2011 and from 393 general practices in Scotland.  The study results were published in the European Journal of Heart Failure.
• Scientists at the University of Texas at Austin are using supercomputers developed and deployed by Texas Advanced Computing Center (TACC) to identify new and better chemo drugs. Read more in Scientific Reports.
• Patients who expressed the tumor antigen NY-ESO-1 had more aggressive cancers and were more likely to die early from their disease, according to a study led by researchers at Roswell Park Cancer Institute.  Their findings were published in the journal Gynecologic Oncology.

Surfing the web, I uncovered these news items worth sharing

• In an important step toward endoscopic diagnosis of cancer, researchers in Germany have developed a handheld fiber optic probe that can be used to perform multiple nonlinear imaging techniques without the need for tissue staining. The imaging probe uses an ultrafast laser to create nonlinear optical effects in tissue that can reveal cancer and other diseases. You can read more about this breakthrough in the Journal of Biophotonics.
• Scientists at Lehigh University have created an artificial intelligence cervical cancer screening technique that may perform as well or even better than human interpretation.  Read more about their findings in the journal Medical Image Analysis.
• The cost of cancer can often create financial hardships for families.  In a recent study by the University of Georgia, researchers found that caring for a husband or wife with cancer can significantly diminish family income. The findings were published in the Journal of Health Economics.
• A new study in JAMA Oncology led by researchers at UC Davis found that second primary cancers in pediatric and adolescents and young adult (AYA) patients are deadlier than they are in older patients. They determined their findings by using data from more than a million (15,954 pediatric, 125,750 AYA and 878,370 older adult) patients with cancer of all ages throughout the United States using the Surveillance, Epidemiology and End Results (SEER) program — 13 registries.